Blog

AAV Manufacturing

How to Evaluate Transfection Reagents in Viral Vector Workflows

Ajmeeta Sangtani

June 22, 2026

Learn how to evaluate transfection reagents for viral vector and biologics production based on efficiency, scalability, downstream impact, reproduc...

Read More

Press Release

SmashGene™ Sets a New Standard in Transfection: Higher Titers Without the Complexity or Cost of Competitor Reagents.

Ajmeeta Sangtani

March 31, 2026

Kyfora Bio today announced the launch of SmashGene™, a next‑generation transfection reagent engineered to deliver higher titers on its own compared...

Read More

Approved Therapies

Approved Cell and Gene Therapies: Regulatory Strategy Across the US and EU

Ajmeeta Sangtani

March 02, 2026

In this blog, we break down the key differences in the regulatory approval processes for cell and gene therapies between the US and EU, offer insig...

Read More

AAV Manufacturing

Navigating Upstream AAV Manufacturing Process Challenges in Next-Gen Bioprocessing

Ajmeeta Sangtani

February 16, 2026

Adeno-associated virus (AAV) vectors have become the dominant delivery platform for gene therapies, with several FDA-approved products and many mor...

Read More

PEI Transfection

Polyethylenimine (PEI) Transfection Protocol Optimization: Dos and Don’ts for High Efficiency

Ajmeeta Sangtani

December 16, 2025

Efficient gene delivery is essential for advancing cell and gene therapies. Polyethylenimine (PEI) transfection has become a widely adopted method ...

Read More